These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32964197)

  • 1. Assessment of the clinical utility of pharmacogenetic guidance in a comprehensive medication management service.
    Rodríguez-Escudero I; Cedeño JA; Rodríguez-Nazario I; Reynaldo-Fernández G; Rodríguez-Vera L; Morales N; Jiménez-Vélez B; Ruaño G; Duconge J
    J Am Coll Clin Pharm; 2020 Sep; 3(6):1028-1037. PubMed ID: 32964197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Utility of Pharmacogenetic Testing and a Clinical Decision Support Tool to Enhance the Identification of Drug Therapy Problems Through Medication Therapy Management in Polypharmacy Patients.
    Kim K; Magness JW; Nelson R; Baron V; Brixner DI
    J Manag Care Spec Pharm; 2018 Dec; 24(12):1250-1259. PubMed ID: 30479202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetic testing and counselling in the community pharmacy: mixed-methods study of a new pharmacist-led service.
    Jeiziner C; Meyer Zu Schwabedissen HE; Hersberger KE; Allemann SS
    Int J Clin Pharm; 2023 Dec; 45(6):1378-1386. PubMed ID: 37338707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nine-gene pharmacogenomics profile service: The Mayo Clinic experience.
    Matey ET; Ragan AK; Oyen LJ; Vitek CR; Aoudia SL; Ragab AK; Fee-Schroeder KC; Black JL; Moyer AM; Nicholson WT; Shrestha S; McAllister TM; Sinnwell JP; Faubion SS; Lazaridis KN
    Pharmacogenomics J; 2022 Feb; 22(1):69-74. PubMed ID: 34671112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
    Del Toro-Pagán NM; Matos A; Thacker D; Turgeon J; Amin NS; Michaud V
    Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing Clinical Utility of Pharmacogenetic Testing in the Military Health System.
    Hellwig LD; Turner C; Olsen C; Libbus J; Markos B; Koehlmoos T; Haigney M; De Castro M; Saunders D
    Mil Med; 2024 Jan; 189(1-2):e198-e204. PubMed ID: 37436924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of a Standardized Medication Therapy Management Plus Approach within Primary Care.
    Schwartz EJ; Turgeon J; Patel J; Patel P; Shah H; Issa AM; Knowlton OV; Knowlton CH; Bain KT
    J Am Board Fam Med; 2017; 30(6):701-714. PubMed ID: 29180545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of a pharmacist-provided pharmacogenomics service in an executive health program.
    Liko I; Corbin L; Tobin E; Aquilante CL; Lee YM
    Am J Health Syst Pharm; 2021 Jun; 78(12):1094-1103. PubMed ID: 33772264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Making the economic value proposition for pharmacist comprehensive medication management (CMM) in primary care: A conceptual framework.
    Tripicchio K; Urick B; Easter J; Ozawa S
    Res Social Adm Pharm; 2020 Oct; 16(10):1416-1421. PubMed ID: 31918964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacist Consult Reports to Support Pharmacogenomics Report Interpretation.
    Bright D; Saadeh C; DeVuyst-Miller S; Sohn M; Choker A; Langerveld A
    Pharmgenomics Pers Med; 2020; 13():719-724. PubMed ID: 33328756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacist-Initiated Pre-Emptive Pharmacogenetic Panel Testing with Clinical Decision Support in Primary Care: Record of PGx Results and Real-World Impact.
    van der Wouden CH; Bank PCD; Özokcu K; Swen JJ; Guchelaar HJ
    Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting.
    Haga SB; LaPointe NM; Cho A; Reed SD; Mills R; Moaddeb J; Ginsburg GS
    Pharmacogenomics; 2014 Sep; 15(13):1677-86. PubMed ID: 25410893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications for pharmacogenomics in pharmacy practice: A scoping review.
    Hayashi M; Hamdy DA; Mahmoud SH
    Res Social Adm Pharm; 2022 Jul; 18(7):3094-3118. PubMed ID: 34474980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Relevance of a 16-Gene Pharmacogenetic Panel Test for Medication Management in a Cohort of 135 Patients.
    Niedrig DF; Rahmany A; Heib K; Hatz KD; Ludin K; Burden AM; Béchir M; Serra A; Russmann S
    J Clin Med; 2021 Jul; 10(15):. PubMed ID: 34361984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of a pharmacist-led pharmacogenomics service for the Program of All-Inclusive Care for the Elderly (PHARM-GENOME-PACE).
    Bain KT; Schwartz EJ; Knowlton OV; Knowlton CH; Turgeon J
    J Am Pharm Assoc (2003); 2018; 58(3):281-289.e1. PubMed ID: 29602745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of a clinical pharmacist-driven comprehensive medication management program in an outpatient wound healing center.
    Rebolledo JA; Rhodes NJ; Valdes AM; Kulekowskis A; Kliethermes MA
    J Am Pharm Assoc (2003); 2022; 62(2):475-480.e3. PubMed ID: 34764034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporation of pharmacogenetic testing into medication therapy management.
    Haga SB; Moaddeb J; Mills R; Patel M; Kraus W; Allen LaPointe NM
    Pharmacogenomics; 2015 Nov; 16(17):1931-41. PubMed ID: 26555559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community pharmacists' experience with pharmacogenetic testing.
    Moaddeb J; Mills R; Haga SB
    J Am Pharm Assoc (2003); 2015; 55(6):587-594. PubMed ID: 26409205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients' perspectives of a pharmacist-provided clinical pharmacogenomics service.
    Martin JL; Lee YM; Corbin LW; Colson R; Aquilante CL
    Pharmacogenomics; 2022 Jun; 23(8):463-474. PubMed ID: 35469451
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence of exposure to pharmacogenetic drugs by the Saudis treated at the health care centers of the Ministry of National Guard.
    Alshabeeb MA; Alyabsi M; Paras B
    Saudi Pharm J; 2022 Aug; 30(8):1181-1192. PubMed ID: 36164570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.